| abstract |
4'-Cyano-α ', α', α'-trifluoro-3- (4-fluorophenylsulfonyl) -2-hydroxy-2-methylpropiono- m -toluidide A pharmaceutical product, a daily dose or dosage regimen comprising (compound of formula I) and tamoxifen. The product comprises a compound of formula I and tamoxifen in a ratio of 25 to 350: 0.5 to 100, respectively. The present invention also relates to a method for providing a patient with an anti-androgen effect and an anti-estrogen effect, wherein the anti-estrogen effect is provided without further increasing the substantially circulating androgen concentration. |